1. Home
  2. QNCX vs BRIA Comparison

QNCX vs BRIA Comparison

Compare QNCX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • BRIA
  • Stock Information
  • Founded
  • QNCX 2012
  • BRIA 2011
  • Country
  • QNCX United States
  • BRIA Singapore
  • Employees
  • QNCX N/A
  • BRIA N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • BRIA
  • Sector
  • QNCX Health Care
  • BRIA
  • Exchange
  • QNCX Nasdaq
  • BRIA NYSE
  • Market Cap
  • QNCX 70.4M
  • BRIA 86.3M
  • IPO Year
  • QNCX 2019
  • BRIA 2024
  • Fundamental
  • Price
  • QNCX $1.60
  • BRIA $2.99
  • Analyst Decision
  • QNCX Strong Buy
  • BRIA
  • Analyst Count
  • QNCX 4
  • BRIA 0
  • Target Price
  • QNCX $9.50
  • BRIA N/A
  • AVG Volume (30 Days)
  • QNCX 139.9K
  • BRIA 28.9K
  • Earning Date
  • QNCX 03-31-2025
  • BRIA 02-19-2025
  • Dividend Yield
  • QNCX N/A
  • BRIA N/A
  • EPS Growth
  • QNCX N/A
  • BRIA N/A
  • EPS
  • QNCX N/A
  • BRIA 92.24
  • Revenue
  • QNCX N/A
  • BRIA $55,755,669.00
  • Revenue This Year
  • QNCX N/A
  • BRIA N/A
  • Revenue Next Year
  • QNCX N/A
  • BRIA N/A
  • P/E Ratio
  • QNCX N/A
  • BRIA $0.03
  • Revenue Growth
  • QNCX N/A
  • BRIA 8.03
  • 52 Week Low
  • QNCX $0.51
  • BRIA $3.16
  • 52 Week High
  • QNCX $2.45
  • BRIA $4.38
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 43.92
  • BRIA N/A
  • Support Level
  • QNCX $1.49
  • BRIA N/A
  • Resistance Level
  • QNCX $1.69
  • BRIA N/A
  • Average True Range (ATR)
  • QNCX 0.14
  • BRIA 0.00
  • MACD
  • QNCX 0.00
  • BRIA 0.00
  • Stochastic Oscillator
  • QNCX 46.15
  • BRIA 0.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

Share on Social Networks: